Reilly lab awarded as a 2025 Pew Biomedical Scholar

The Pew Charitable Trusts today announced the 22 researchers joining the Pew Scholars Program in the Biomedical Sciences. These early-career scientists will receive four years of funding to uncover fundamental insights about human health and disease. The 2025 class—all early-career, junior faculty—marks the 40th group of Pew scholars to be awarded funding since the program’s founding in 1985.

Scholars were chosen from 209 applicants nominated by leading academic institutions and researchers throughout the United States. This year’s class includes scientists who are assessing how gut bacteria fights metabolic disease, examining the way the human brain develops and evolves over time, and leveraging cutting-edge technologies to prevent and treat disease.

The Reilly lab was funded to design programmable, synthetic cis-regulatory elements—DNA sequences that control gene expression—to facilitate the delivery and activation of therapeutic cargos to specific target tissues.

More info can be found here.